Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWOG S0800: Neoadjuvant Nab-Paclitaxel and Bevacizumab in HER2-Negative Breast Cancer
NCT00856492Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2010
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by SWOG Cancer Research Network. Started Apr 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00856492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856492.